001     155732
005     20240209160645.0
024 7 _ |a 10.1016/j.neurobiolaging.2021.03.003
|2 doi
024 7 _ |a pmid:33845399
|2 pmid
024 7 _ |a 0197-4580
|2 ISSN
024 7 _ |a 1558-1497
|2 ISSN
024 7 _ |a altmetric:101654759
|2 altmetric
037 _ _ |a DZNE-2021-00900
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Babiloni, Claudio
|b 0
245 _ _ |a EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panel.
260 _ _ |a Amsterdam [u.a.]
|c 2021
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1707491159_2406
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Vascular contribution to cognitive impairment (VCI) and dementia is related to etiologies that may affect the neurophysiological mechanisms regulating brain arousal and generating electroencephalographic (EEG) activity. A multidisciplinary expert panel reviewed the clinical literature and reached consensus about the EEG measures consistently found as abnormal in VCI patients with dementia. As compared to cognitively unimpaired individuals, those VCI patients showed (1) smaller amplitude of resting state alpha (8-12 Hz) rhythms dominant in posterior regions; (2) widespread increases in amplitude of delta (< 4 Hz) and theta (4-8 Hz) rhythms; and (3) delayed N200/P300 peak latencies in averaged event-related potentials, especially during the detection of auditory rare target stimuli requiring participants' responses in 'oddball' paradigms. The expert panel formulated the following recommendations: (1) the above EEG measures are not specific for VCI and should not be used for its diagnosis; (2) they may be considered as 'neural synchronization' biomarkers to enlighten the relationships between features of the VCI-related cerebrovascular lesions and abnormalities in neurophysiological brain mechanisms; and (3) they may be tested in future clinical trials as prognostic biomarkers and endpoints of interventions aimed at normalizing background brain excitability and vigilance in wakefulness.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Cerebrovascular disease (CVD)
|2 Other
650 _ 7 |a Event-related oscillations (EROs)
|2 Other
650 _ 7 |a Event-related potentials (ERPs)
|2 Other
650 _ 7 |a Resting state electroencephalographic (rsEEG) rhythms
|2 Other
650 _ 7 |a Small vessel disease
|2 Other
650 _ 7 |a Subcortical ischemic vascular disease
|2 Other
650 _ 7 |a Vascular cognitive impairment (VCI)
|2 Other
650 _ 7 |a Vascular contribution to cognitive impairment and dementia (VCID)
|2 Other
650 _ 7 |a Vascular dementia (VaD)
|2 Other
650 _ 2 |a Brain: physiopathology
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: diagnosis
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: etiology
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: physiopathology
|2 MeSH
650 _ 2 |a Dementia, Vascular: diagnosis
|2 MeSH
650 _ 2 |a Dementia, Vascular: etiology
|2 MeSH
650 _ 2 |a Dementia, Vascular: physiopathology
|2 MeSH
650 _ 2 |a Electroencephalography: methods
|2 MeSH
650 _ 2 |a Evoked Potentials: physiology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Rest: physiology
|2 MeSH
700 1 _ |a Arakaki, Xianghong
|b 1
700 1 _ |a Bonanni, Laura
|b 2
700 1 _ |a Bujan, Ana
|b 3
700 1 _ |a Carrillo, Maria C
|b 4
700 1 _ |a Del Percio, Claudio
|b 5
700 1 _ |a Edelmayer, Rebecca M
|b 6
700 1 _ |a Egan, Gary
|b 7
700 1 _ |a Elahh, Fanny M
|b 8
700 1 _ |a Evans, Alan
|b 9
700 1 _ |a Ferri, Raffaele
|b 10
700 1 _ |a Frisoni, Giovanni B
|0 P:(DE-2719)9001538
|b 11
|u dzne
700 1 _ |a Güntekin, Bahar
|b 12
700 1 _ |a Hainsworth, Atticus
|b 13
700 1 _ |a Hampel, Harald
|b 14
700 1 _ |a Jelic, Vesna
|b 15
700 1 _ |a Jeong, Jaeseung
|b 16
700 1 _ |a Kim, Doh Kwan
|b 17
700 1 _ |a Kramberger, Milica
|b 18
700 1 _ |a Kumar, Sanjeev
|b 19
700 1 _ |a Lizio, Roberta
|b 20
700 1 _ |a Nobili, Flavio
|b 21
700 1 _ |a Noce, Giuseppe
|b 22
700 1 _ |a Puce, Aina
|b 23
700 1 _ |a Ritter, Petra
|b 24
700 1 _ |a Smit, Dirk J A
|b 25
700 1 _ |a Soricelli, Andrea
|b 26
700 1 _ |a Teipel, Stefan
|0 P:(DE-2719)2000026
|b 27
|u dzne
700 1 _ |a Tucci, Federico
|b 28
700 1 _ |a Sachdev, Perminder
|b 29
700 1 _ |a Valdes-Sosa, Mitchell
|b 30
700 1 _ |a Valdes-Sosa, Pedro
|b 31
700 1 _ |a Vergallo, Andrea
|b 32
700 1 _ |a Yener, Görsev
|b 33
773 _ _ |a 10.1016/j.neurobiolaging.2021.03.003
|g Vol. 103, p. 78 - 97
|0 PERI:(DE-600)1498414-3
|p 78 - 97
|t Neurobiology of aging
|v 103
|y 2021
|x 0197-4580
856 4 _ |u https://pub.dzne.de/record/155732/files/DZNE-2021-00900_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/155732/files/DZNE-2021-00900_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:155732
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 11
|6 P:(DE-2719)9001538
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 27
|6 P:(DE-2719)2000026
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-28
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-10
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROBIOL AGING : 2021
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-10
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-10
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NEUROBIOL AGING : 2021
|d 2022-11-10
920 1 _ |0 I:(DE-2719)1510100
|k AG Teipel
|l Clinical Dementia Research (Rostock /Greifswald)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1510100
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21